As we move through 2026, the industry is undergoing a "Collaboration Metamorphosis." This year, the Primary Sclerosing Cholangitis Market has reached a "Registry Milestone," where global patient databases like the UK-PSC Registry have successfully linked over 20,000 patients to active clinical trials. This is proving essential for the 2026 "Evidence Generation" goal, as the biggest hurdle to...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
china 
thai
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)